{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T20:57:57Z","timestamp":1782853077679,"version":"3.54.5"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T00:00:00Z","timestamp":1750464000000},"content-version":"vor","delay-in-days":20,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82230005, 81873432, 82200133, 82200137, and 82070143"],"award-info":[{"award-number":["82230005, 81873432, 82200133, 82200137, and 82070143"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s00277-025-06451-6","type":"journal-article","created":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T00:41:40Z","timestamp":1750466500000},"page":"3271-3279","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of ETV6 mutations on clinical outcomes in acute myeloid leukemia: a real-world retrospective cohort study"],"prefix":"10.1007","volume":"104","author":[{"given":"Xueqian","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haohao","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqian","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifang","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Depei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7560-7195","authenticated-orcid":false,"given":"Yue","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,21]]},"reference":[{"issue":"2","key":"6451_CR1","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/0092-8674(94)90322-0","volume":"77","author":"TR Golub","year":"1994","unstructured":"Golub TR, Barker GF, Lovett M, Gilliland DG (1994) Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 77(2):307\u2013316. https:\/\/doi.org\/10.1016\/0092-8674(94)90322-0","journal-title":"Cell"},{"issue":"2","key":"6451_CR2","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1053\/j.seminhematol.2017.04.005","volume":"54","author":"H Hock","year":"2017","unstructured":"Hock H, Shimamura A (2017) ETV6 in hematopoiesis and leukemia predisposition. Semin Hematol 54(2):98\u2013104. https:\/\/doi.org\/10.1053\/j.seminhematol.2017.04.005","journal-title":"Semin Hematol"},{"issue":"6","key":"6451_CR3","doi-asserted-by":"publisher","first-page":"e1005262","DOI":"10.1371\/journal.pgen.1005262","volume":"11","author":"S Topka","year":"2015","unstructured":"Topka S, Vijai J, Walsh MF, Jacobs L, Maria A, Villano D, Gaddam P, Wu G, McGee RB, Quinn E, Inaba H, Hartford C, Pui CH, Pappo A, Edmonson M, Zhang MY, Stepensky P, Steinherz P, Schrader K, Lincoln A, Bussel J, Lipkin SM, Goldgur Y, Harit M, Stadler ZK, Mullighan C, Weintraub M, Shimamura A, Zhang J, Downing JR, Nichols KE, Offit K (2015) Germline ETV6 mutations confer susceptibility to acute lymphoblastic leukemia and thrombocytopenia. PLoS Genet 11(6):e1005262. https:\/\/doi.org\/10.1371\/journal.pgen.1005262","journal-title":"PLoS Genet"},{"issue":"5","key":"6451_CR4","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/ng.3253","volume":"47","author":"L Noetzli","year":"2015","unstructured":"Noetzli L, Lo RW, Lee-Sherick AB, Callaghan M, Noris P, Savoia A, Rajpurkar M, Jones K, Gowan K, Balduini C, Pecci A, Gnan C, De Rocco D, Doubek M, Li L, Lu L, Leung R, Landolt-Marticorena C, Hunger S, Heller P, Gutierrez-Hartmann A, Xiayuan L, Pluthero FG, Rowley JW, Weyrich AS, Kahr WHA, Porter CC, Di Paola J (2015) Germline mutations in ETV6 are associated with thrombocytopenia, red cell macrocytosis and predisposition to lymphoblastic leukemia. Nat Genet 47(5):535\u2013538. https:\/\/doi.org\/10.1038\/ng.3253","journal-title":"Nat Genet"},{"issue":"26","key":"6451_CR5","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1056\/NEJMoa1013343","volume":"364","author":"R Bejar","year":"2011","unstructured":"Bejar R, Stevenson K, Abdel-Wahab O, Galili N, Nilsson B, Garcia-Manero G, Kantarjian H, Raza A, Levine RL, Neuberg D, Ebert BL (2011) Clinical effect of point mutations in myelodysplastic syndromes. N Engl J Med 364(26):2496\u20132506. https:\/\/doi.org\/10.1056\/NEJMoa1013343","journal-title":"N Engl J Med"},{"issue":"13","key":"6451_CR6","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1084\/jem.20112239","volume":"208","author":"P Van Vlierberghe","year":"2011","unstructured":"Van Vlierberghe P, Ambesi-Impiombato A, Perez-Garcia A, Haydu JE, Rigo I, Hadler M, Tosello V, Della Gatta G, Paietta E, Racevskis J, Wiernik PH, Luger SM, Rowe JM, Rue M, Ferrando AA (2011) ETV6 mutations in early immature human T cell leukemias. J Exp Med 208(13):2571\u20132579. https:\/\/doi.org\/10.1084\/jem.20112239","journal-title":"J Exp Med"},{"issue":"1","key":"6451_CR7","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1182\/blood-2011-01-331678","volume":"118","author":"T Klampfl","year":"2011","unstructured":"Klampfl T, Harutyunyan A, Berg T, Gisslinger B, Schalling M, Bagienski K, Olcaydu D, Passamonti F, Rumi E, Pietra D, J\u00e4ger R, Pieri L, Guglielmelli P, Iacobucci I, Martinelli G, Cazzola M, Vannucchi AM, Gisslinger H, Kralovics R (2011) Genome integrity of myeloproliferative neoplasms in chronic phase and during disease progression. Blood 118(1):167\u2013176. https:\/\/doi.org\/10.1182\/blood-2011-01-331678","journal-title":"Blood"},{"issue":"11","key":"6451_CR8","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1056\/NEJMoa1403088","volume":"371","author":"KG Roberts","year":"2014","unstructured":"Roberts KG, Li Y, Payne-Turner D, Harvey RC, Yang YL, Pei D, McCastlain K, Ding L, Lu C, Song G, Ma J, Becksfort J, Rusch M, Chen SC, Easton J, Cheng J, Boggs K, Santiago-Morales N, Iacobucci I, Fulton RS, Wen J, Valentine M, Cheng C, Paugh SW, Devidas M, Chen IM, Reshmi S, Smith A, Hedlund E, Gupta P, Nagahawatte P, Wu G, Chen X, Yergeau D, Vadodaria B, Mulder H, Winick NJ, Larsen EC, Carroll WL, Heerema NA, Carroll AJ, Grayson G, Tasian SK, Moore AS, Keller F, Frei-Jones M, Whitlock JA, Raetz EA, White DL, Hughes TP, Guidry Auvil JM, Smith MA, Marcucci G, Bloomfield CD, Mr\u00f3zek K, Kohlschmidt J, Stock W, Kornblau SM, Konopleva M, Paietta E, Pui CH, Jeha S, Relling MV, Evans WE, Gerhard DS, Gastier-Foster JM, Mardis E, Wilson RK, Loh ML, Downing JR, Hunger SP, Willman CL, Zhang J, Mullighan CG (2014) Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. N Engl J Med 371(11):1005\u20131015. https:\/\/doi.org\/10.1056\/NEJMoa1403088","journal-title":"N Engl J Med"},{"issue":"23","key":"6451_CR9","doi-asserted-by":"publisher","first-page":"3675","DOI":"10.1182\/blood-2014-03-562637","volume":"123","author":"E Padron","year":"2014","unstructured":"Padron E, Yoder S, Kunigal S, Mesa T, Teer JK, Al Ali N, Sekeres MA, Painter JS, Zhang L, Lancet J, Maciejewski JP, Epling-Burnette PK, Sotomayor E, Komrokji RS, List AF (2014) ETV6 and signaling gene mutations are associated with secondary transformation of myelodysplastic syndromes to chronic myelomonocytic leukemia. Blood 123(23):3675\u20133677. https:\/\/doi.org\/10.1182\/blood-2014-03-562637","journal-title":"Blood"},{"issue":"10","key":"6451_CR10","doi-asserted-by":"publisher","first-page":"e176","DOI":"10.3324\/haematol.2014.104406","volume":"99","author":"Q Wang","year":"2014","unstructured":"Wang Q, Dong S, Yao H, Wen L, Qiu H, Qin L, Ma L, Chen S (2014) ETV6 mutation in a cohort of 970 patients with hematologic malignancies. Haematologica 99(10):e176\u2013178. https:\/\/doi.org\/10.3324\/haematol.2014.104406","journal-title":"Haematologica"},{"key":"6451_CR11","doi-asserted-by":"publisher","first-page":"n2026","DOI":"10.1136\/bmj.n2026","volume":"375","author":"LF Newell","year":"2021","unstructured":"Newell LF, Cook RJ (2021) Advances in acute myeloid leukemia. Bmj 375:n2026. https:\/\/doi.org\/10.1136\/bmj.n2026","journal-title":"Bmj"},{"issue":"23","key":"6451_CR12","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","volume":"374","author":"E Papaemmanuil","year":"2016","unstructured":"Papaemmanuil E, Gerstung M, Bullinger L, Gaidzik VI, Paschka P, Roberts ND, Potter NE, Heuser M, Thol F, Bolli N, Gundem G, Van Loo P, Martincorena I, Ganly P, Mudie L, McLaren S, O\u2019Meara S, Raine K, Jones DR, Teague JW, Butler AP, Greaves MF, Ganser A, D\u00f6hner K, Schlenk RF, D\u00f6hner H, Campbell PJ (2016) Genomic classification and prognosis in acute myeloid leukemia. N Engl J Med 374(23):2209\u20132221. https:\/\/doi.org\/10.1056\/NEJMoa1516192","journal-title":"N Engl J Med"},{"issue":"5","key":"6451_CR13","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1182\/blood-2016-01-693879","volume":"128","author":"KH Metzeler","year":"2016","unstructured":"Metzeler KH, Herold T, Rothenberg-Thurley M, Amler S, Sauerland MC, G\u00f6rlich D, Schneider S, Konstandin NP, Dufour A, Br\u00e4undl K, Ksienzyk B, Zellmeier E, Hartmann L, Greif PA, Fiegl M, Subklewe M, Bohlander SK, Krug U, Faldum A, Berdel WE, W\u00f6rmann B, B\u00fcchner T, Hiddemann W, Braess J, Spiekermann K (2016) Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia. Blood 128(5):686\u2013698. https:\/\/doi.org\/10.1182\/blood-2016-01-693879","journal-title":"Blood"},{"issue":"11","key":"6451_CR14","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1002\/ajh.26314","volume":"96","author":"Y Alwash","year":"2021","unstructured":"Alwash Y, Khoury JD, Tashakori M, Kanagal-Shamanna R, Daver N, Ravandi F, Kadia TM, Konopleva M, Dinardo CD, Issa GC, Loghavi S, Takahashi K, Jabbour E, Guerra V, Kornblau S, Kantarjian H, Short NJ (2021) Development of TP53 mutations over the course of therapy for acute myeloid leukemia. Am J Hematol 96(11):1420\u20131428. https:\/\/doi.org\/10.1002\/ajh.26314","journal-title":"Am J Hematol"},{"issue":"2","key":"6451_CR15","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/leu.2017.239","volume":"32","author":"A Stengel","year":"2018","unstructured":"Stengel A, Kern W, Meggendorfer M, Nadarajah N, Perglerov\u00e0 K, Haferlach T, Haferlach C (2018) Number of RUNX1 mutations, wild-type allele loss and additional mutations impact on prognosis in adult RUNX1-mutated AML. Leukemia 32(2):295\u2013302. https:\/\/doi.org\/10.1038\/leu.2017.239","journal-title":"Leukemia"},{"issue":"5","key":"6451_CR16","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41408-021-00495-3","volume":"11","author":"N Daver","year":"2021","unstructured":"Daver N, Venugopal S, Ravandi F (2021) FLT3 mutated acute myeloid leukemia: 2021 treatment algorithm. Blood Cancer J 11(5):104. https:\/\/doi.org\/10.1038\/s41408-021-00495-3","journal-title":"Blood Cancer J"},{"issue":"25","key":"6451_CR17","doi-asserted-by":"publisher","first-page":"4129","DOI":"10.1038\/sj.onc.1208588","volume":"24","author":"S van Doorn-Khosrovani","year":"2005","unstructured":"Barjesteh van Waalwijk, van Doorn-Khosrovani S, Spensberger D, de Knegt Y, Tang M, L\u00f6wenberg B, Delwel R (2005) Somatic heterozygous mutations in ETV6 (TEL) and frequent absence of ETV6 protein in acute myeloid leukemia. Oncogene 24(25):4129\u20134137. https:\/\/doi.org\/10.1038\/sj.onc.1208588","journal-title":"Oncogene"},{"issue":"1","key":"6451_CR18","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1006\/geno.1998.5685","volume":"56","author":"M Baens","year":"1999","unstructured":"Baens M, Wlodarska I, Corveleyn A, Hoornaert I, Hagemeijer A, Marynen P (1999) A physical, transcript, and deletion map of chromosome region 12p12.3 flanked by ETV6 and CDKN1B: hypermethylation of the LRP6 CpG Island in two leukemia patients with hemizygous del(12p). Genomics 56(1):40\u201350. https:\/\/doi.org\/10.1006\/geno.1998.5685","journal-title":"Genomics"},{"issue":"3","key":"6451_CR19","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1182\/blood-2009-11-254441","volume":"116","author":"D Grimwade","year":"2010","unstructured":"Grimwade D, Hills RK, Moorman AV, Walker H, Chatters S, Goldstone AH, Wheatley K, Harrison CJ, Burnett AK (2010) Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the united Kingdom medical research Council trials. Blood 116(3):354\u2013365. https:\/\/doi.org\/10.1182\/blood-2009-11-254441","journal-title":"Blood"},{"issue":"4","key":"6451_CR20","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","volume":"129","author":"H D\u00f6hner","year":"2017","unstructured":"D\u00f6hner H, Estey E, Grimwade D, Amadori S, Appelbaum FR, B\u00fcchner T, Dombret H, Ebert BL, Fenaux P, Larson RA, Levine RL, Lo-Coco F, Naoe T, Niederwieser D, Ossenkoppele GJ, Sanz M, Sierra J, Tallman MS, Tien HF, Wei AH, L\u00f6wenberg B, Bloomfield CD (2017) Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood 129(4):424\u2013447. https:\/\/doi.org\/10.1182\/blood-2016-08-733196","journal-title":"Blood"},{"issue":"4","key":"6451_CR21","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/gcc.21918","volume":"51","author":"C Haferlach","year":"2012","unstructured":"Haferlach C, Bacher U, Schnittger S, Alpermann T, Zenger M, Kern W, Haferlach T (2012) ETV6 rearrangements are recurrent in myeloid malignancies and are frequently associated with other genetic events. Genes Chromosomes Cancer 51(4):328\u2013337. https:\/\/doi.org\/10.1002\/gcc.21918","journal-title":"Genes Chromosomes Cancer"},{"issue":"4","key":"6451_CR22","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1111\/bjh.16341","volume":"190","author":"Z Herudkova","year":"2020","unstructured":"Herudkova Z, Culen M, Folta A, Jeziskova I, Cerna J, Loja T, Tom N, Smejkal J, Semerad L, Dvorakova D, Mayer J, Racil Z (2020) Clonal hierarchy of main molecular lesions in acute myeloid leukaemia. Br J Haematol 190(4):562\u2013572. https:\/\/doi.org\/10.1111\/bjh.16341","journal-title":"Br J Haematol"},{"issue":"1","key":"6451_CR23","doi-asserted-by":"publisher","first-page":"18622","DOI":"10.1038\/s41598-020-74744-z","volume":"10","author":"H Wang","year":"2020","unstructured":"Wang H, Guo Y, Dong Z, Li T, Xie X, Wan D, Jiang Z, Yu J, Guo R (2020) Differential U2AF1 mutation sites, burden and co-mutation genes can predict prognosis in patients with myelodysplastic syndrome. Sci Rep 10(1):18622. https:\/\/doi.org\/10.1038\/s41598-020-74744-z","journal-title":"Sci Rep"},{"issue":"4","key":"6451_CR24","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1111\/bjh.17675","volume":"194","author":"I Mart\u00edn","year":"2021","unstructured":"Mart\u00edn I, Villam\u00f3n E, Abell\u00e1n R, Calasanz MJ, Irigoyen A, Sanz G, Such E, Mora E, Guti\u00e9rrez M, Collado R, Garc\u00eda-Serra R, Vara M, Blanco ML, Oiartzabal I, \u00c1lvarez S, Bernal T, Granada I, Xicoy B, Jerez A, Calabuig M, Diez R, Gil \u00c1, D\u00edez-Campelo M, Solano C, Tormo M (2021) Myelodysplastic syndromes with 20q deletion: incidence, prognostic value and impact on response to Azacitidine of ASXL1 chromosomal deletion and genetic mutations. Br J Haematol 194(4):708\u2013717. https:\/\/doi.org\/10.1111\/bjh.17675","journal-title":"Br J Haematol"},{"issue":"4","key":"6451_CR25","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.devcel.2010.02.009","volume":"18","author":"A Ciau-Uitz","year":"2010","unstructured":"Ciau-Uitz A, Pinheiro P, Gupta R, Enver T, Patient R (2010) Tel1\/ETV6 specifies blood stem cells through the agency of VEGF signaling. Dev Cell 18(4):569\u2013578. https:\/\/doi.org\/10.1016\/j.devcel.2010.02.009","journal-title":"Dev Cell"},{"issue":"19","key":"6451_CR26","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1101\/gad.1239604","volume":"18","author":"H Hock","year":"2004","unstructured":"Hock H, Meade E, Medeiros S, Schindler JW, Valk PJ, Fujiwara Y, Orkin SH (2004) Tel\/Etv6 is an essential and selective regulator of adult hematopoietic stem cell survival. Genes Dev 18(19):2336\u20132341. https:\/\/doi.org\/10.1101\/gad.1239604","journal-title":"Genes Dev"},{"issue":"2","key":"6451_CR27","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3324\/haematol.2016.147694","volume":"102","author":"M Poggi","year":"2017","unstructured":"Poggi M, Canault M, Favier M, Turro E, Saultier P, Ghalloussi D, Baccini V, Vidal L, Mezzapesa A, Chelghoum N, Mohand-Oumoussa B, Falaise C, Favier R, Ouwehand WH, Fiore M, Peiretti F, Morange PE, Saut N, Bernot D, Greinacher A, BioResource N, Nurden AT, Nurden P, Freson K, Tr\u00e9gou\u00ebt DA, Raslova H, Alessi MC (2017) Germline variants in ETV6 underlie reduced platelet formation, platelet dysfunction and increased levels of circulating CD34\u2009+\u2009progenitors. Haematologica 102(2):282\u2013294. https:\/\/doi.org\/10.3324\/haematol.2016.147694","journal-title":"Haematologica"},{"issue":"4","key":"6451_CR28","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1111\/j.1349-7006.2009.01097.x","volume":"100","author":"M Eguchi-Ishimae","year":"2009","unstructured":"Eguchi-Ishimae M, Eguchi M, Maki K, Porcher C, Shimizu R, Yamamoto M, Mitani K (2009) Leukemia-related transcription factor TEL\/ETV6 expands erythroid precursors and stimulates hemoglobin synthesis. Cancer Sci 100(4):689\u2013697. https:\/\/doi.org\/10.1111\/j.1349-7006.2009.01097.x","journal-title":"Cancer Sci"},{"issue":"6","key":"6451_CR29","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1016\/j.stemcr.2021.04.013","volume":"16","author":"S Borst","year":"2021","unstructured":"Borst S, Nations CC, Klein JG, Pavani G, Maguire JA, Camire RM, Drazer MW, Godley LA, French DL, Poncz M, Gadue P (2021) Study of inherited thrombocytopenia resulting from mutations in ETV6 or RUNX1 using a human pluripotent stem cell model. Stem Cell Rep 16(6):1458\u20131467. https:\/\/doi.org\/10.1016\/j.stemcr.2021.04.013","journal-title":"Stem Cell Rep"},{"issue":"8","key":"6451_CR30","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1128\/mcb.24.8.3227-3237.2004","volume":"24","author":"K Maki","year":"2004","unstructured":"Maki K, Arai H, Waga K, Sasaki K, Nakamura F, Imai Y, Kurokawa M, Hirai H, Mitani K (2004) Leukemia-related transcription factor TEL is negatively regulated through extracellular signal-regulated kinase-induced phosphorylation. Mol Cell Biol 24(8):3227\u20133237. https:\/\/doi.org\/10.1128\/mcb.24.8.3227-3237.2004","journal-title":"Mol Cell Biol"},{"issue":"12","key":"6451_CR31","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1056\/NEJMra1406184","volume":"373","author":"H D\u00f6hner","year":"2015","unstructured":"D\u00f6hner H, Weisdorf DJ, Bloomfield CD (2015) Acute myeloid leukemia. N Engl J Med 373(12):1136\u20131152. https:\/\/doi.org\/10.1056\/NEJMra1406184","journal-title":"N Engl J Med"},{"issue":"9","key":"6451_CR32","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.3324\/haematol.2020.254623","volume":"106","author":"E Onecha","year":"2021","unstructured":"Onecha E, Rapado I, Luz Morales M, Carre\u00f1o-Tarragona G, Martinez-Sanchez P, Gutierrez X, S\u00e1chez Pina JM, Linares M, Gallardo M, Martinez-L\u00f3pez J, Ayala R (2021) Monitoring of clonal evolution of acute myeloid leukemia identifies the leukemia subtype, clinical outcome and potential new drug targets for post-remission strategies or relapse. Haematologica 106(9):2325\u20132333. https:\/\/doi.org\/10.3324\/haematol.2020.254623","journal-title":"Haematologica"},{"issue":"9","key":"6451_CR33","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1182\/blood.2019001982","volume":"136","author":"S DeWolf","year":"2020","unstructured":"DeWolf S, Tallman MS (2020) How I treat relapsed or refractory AML. Blood 136(9):1023\u20131032. https:\/\/doi.org\/10.1182\/blood.2019001982","journal-title":"Blood"},{"issue":"5","key":"6451_CR34","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1002\/ajh.27625","volume":"100","author":"S Shimony","year":"2025","unstructured":"Shimony S, Stahl M, Stone RM (2025) Acute myeloid leukemia: 2025 update on diagnosis, risk-stratification, and management. Am J Hematol 100(5):860\u2013891. https:\/\/doi.org\/10.1002\/ajh.27625","journal-title":"Am J Hematol"},{"issue":"2","key":"6451_CR35","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/ng.3177","volume":"47","author":"MY Zhang","year":"2015","unstructured":"Zhang MY, Churpek JE, Keel SB, Walsh T, Lee MK, Loeb KR, Gulsuner S, Pritchard CC, Sanchez-Bonilla M, Delrow JJ, Basom RS, Forouhar M, Gyurkocza B, Schwartz BS, Neistadt B, Marquez R, Mariani CJ, Coats SA, Hofmann I, Lindsley RC, Williams DA, Abkowitz JL, Horwitz MS, King MC, Godley LA, Shimamura A (2015) Germline ETV6 mutations in familial thrombocytopenia and hematologic malignancy. Nat Genet 47(2):180\u2013185. https:\/\/doi.org\/10.1038\/ng.3177","journal-title":"Nat Genet"},{"issue":"8","key":"6451_CR36","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1182\/blood.2019852418","volume":"134","author":"J Di Paola","year":"2019","unstructured":"Di Paola J, Porter CC (2019) ETV6-related thrombocytopenia and leukemia predisposition. Blood 134(8):663\u2013667. https:\/\/doi.org\/10.1182\/blood.2019852418","journal-title":"Blood"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06451-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-025-06451-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06451-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T08:01:12Z","timestamp":1753171272000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-025-06451-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["6451"],"URL":"https:\/\/doi.org\/10.1007\/s00277-025-06451-6","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"8 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted with the approval of the Research Ethical Review Committee of the First Affiliated Hospital of Soochow University, following institutional guidelines and in accordance with the principles outlined in the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}